Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Theme Switcher
Night Mode
Recombinant protein therapeutics CDMO Industry Analysis and Forecast to 2032
The Recombinant Protein Therapeutics CDMO Market is gaining substantial momentum as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations (CDMOs). Valued at USD 20,920.32 million in 2024, the market is projected to expand at a robust CAGR of 13.98% from 2025 to 2032. Growth is driven...
Angry
14
· 0 Comments ·0 Shares ·266 Views
Please log in to like, share and comment!
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
VXEngine https://vxengine.ru